JPH0770117A - ４−アリールオキシ−および４−アリールチオピペリジン誘導体 - Google Patents

４−アリールオキシ−および４−アリールチオピペリジン誘導体

Info

Publication number
JPH0770117A
JPH0770117A JP6168105A JP16810594A JPH0770117A JP H0770117 A JPH0770117 A JP H0770117A JP 6168105 A JP6168105 A JP 6168105A JP 16810594 A JP16810594 A JP 16810594A JP H0770117 A JPH0770117 A JP H0770117A
Authority
JP
Japan
Prior art keywords
general formula
oxazolidinone
compound
methyl
methoxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6168105A
Other languages
English (en)
Japanese (ja)
Inventor
Helmut Pruecher
プリュッヒャー ヘルムート
Rudolf Gottschlich
ゴットシュリッヒ ルードルフ
Gerd Bartoszyk
バルトシーク ゲルト
Christoph Seyfried
ザイフリート クリストフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of JPH0770117A publication Critical patent/JPH0770117A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP6168105A 1993-07-21 1994-07-20 ４−アリールオキシ−および４−アリールチオピペリジン誘導体 Pending JPH0770117A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4324393A DE4324393A1 (de) 1993-07-21 1993-07-21 4-Aryloxy- und 4-Arylthiopiperidinderivate
DE4324393-2 1993-07-21

Publications (1)

Publication Number Publication Date
JPH0770117A true JPH0770117A (ja) 1995-03-14

Family

ID=6493312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6168105A Pending JPH0770117A (ja) 1993-07-21 1994-07-20 ４−アリールオキシ−および４−アリールチオピペリジン誘導体

Country Status (21)

Country Link
US (1) US5561145A (de)
EP (1) EP0635505B1 (de)
JP (1) JPH0770117A (de)
KR (1) KR100354303B1 (de)
CN (1) CN1055690C (de)
AT (1) ATE159252T1 (de)
AU (1) AU683886B2 (de)
CA (1) CA2128380C (de)
CZ (1) CZ284544B6 (de)
DE (2) DE4324393A1 (de)
DK (1) DK0635505T3 (de)
ES (1) ES2110660T3 (de)
GR (1) GR3025880T3 (de)
HU (1) HU218912B (de)
NO (1) NO301477B1 (de)
PL (1) PL177692B1 (de)
RU (1) RU2135495C1 (de)
SK (1) SK281630B6 (de)
TW (1) TW401417B (de)
UA (1) UA43828C2 (de)
ZA (1) ZA945340B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DK0710657T3 (da) * 1994-11-02 1999-05-25 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE19504954A1 (de) * 1995-02-15 1996-08-22 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
DE19524765A1 (de) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19531321A1 (de) * 1995-08-25 1997-02-27 Merck Patent Gmbh Piperidinylmethyloxazolidinone
US5977138A (en) * 1996-08-15 1999-11-02 Schering Corporation Ether muscarinic antagonists
DE19707628A1 (de) * 1997-02-26 1998-08-27 Merck Patent Gmbh Oxazolidinone
US7408067B2 (en) 2002-01-17 2008-08-05 Merck + Co., Inc. Aza-cyclic compounds as modulators of acetylcholine receptors
FR2891165B1 (fr) * 2005-09-28 2008-01-11 Cryo Bio System Sa Ensemble de conditionnement d'un volume predetermine de substance a conserver par vitrification cryogenique.
FR2891166B1 (fr) * 2005-09-28 2007-11-23 Cryo Bio System Sa Enveloppe de conditionnement d'un volume predetermine de substance biologique destinee a etre plongee dans un agent cryogenique liquide
EP1963261A1 (de) * 2005-12-21 2008-09-03 Decode Genetics EHF Biarylsubstituierte, stickstoffhaltige heterocyclische inhibitoren von lta4h zur behandlung von enzündungen
US11186564B2 (en) * 2016-08-04 2021-11-30 Sunovion Pharmaceuticals Inc. Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
AU607735B2 (en) * 1987-05-07 1991-03-14 A.H. Robins Company, Incorporated Novel cyclic carbamate derivatives
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
DE4005371A1 (de) * 1990-02-21 1991-08-22 Merck Patent Gmbh Oxazolidinone
DE4017211A1 (de) * 1990-05-29 1991-12-05 Merck Patent Gmbh Oxazolidinone
JP3084729B2 (ja) * 1990-06-15 2000-09-04 横河電機株式会社 デジタルオシロスコープ

Also Published As

Publication number Publication date
PL177692B1 (pl) 2000-01-31
ES2110660T3 (es) 1998-02-16
KR100354303B1 (ko) 2002-12-11
AU6753694A (en) 1995-02-02
CA2128380C (en) 2005-04-12
DE4324393A1 (de) 1995-01-26
TW401417B (en) 2000-08-11
NO301477B1 (no) 1997-11-03
ZA945340B (en) 1995-03-01
PL304349A1 (en) 1995-01-23
CN1106008A (zh) 1995-08-02
RU2135495C1 (ru) 1999-08-27
HUT71110A (en) 1995-11-28
SK85294A3 (en) 1995-03-08
AU683886B2 (en) 1997-11-27
EP0635505B1 (de) 1997-10-15
NO942715L (no) 1995-01-23
UA43828C2 (uk) 2002-01-15
RU94026079A (ru) 1996-05-27
CZ173894A3 (en) 1995-05-17
NO942715D0 (no) 1994-07-20
HU218912B (hu) 2000-12-28
EP0635505A1 (de) 1995-01-25
DK0635505T3 (da) 1998-06-02
HU9402154D0 (en) 1994-09-28
CZ284544B6 (cs) 1998-12-16
DE59404319D1 (de) 1997-11-20
ATE159252T1 (de) 1997-11-15
CA2128380A1 (en) 1995-01-22
GR3025880T3 (en) 1998-04-30
SK281630B6 (sk) 2001-06-11
KR950003290A (ko) 1995-02-16
US5561145A (en) 1996-10-01
CN1055690C (zh) 2000-08-23

Similar Documents

Publication Publication Date Title
JP3810837B2 (ja) 接着受容体拮抗物質
JP3874837B2 (ja) ベンゾフラン化合物
JP3834098B2 (ja) ベンゾニトリル類およびベンゾフルオリド類
JP4202438B2 (ja) 接着性レセプター拮抗化合物
JPH0770117A (ja) ４−アリールオキシ−および４−アリールチオピペリジン誘導体
RU2155762C2 (ru) Производные оксазолидина, способ их получения, фармацевтическая композиция
US6462056B1 (en) Oxazolidines as 5-HT2A-antagonists
AU715785B2 (en) 1-(pyrazol-3-ylethyl)-4-(indol-3-yl) piperdines as compositions affecting the central nervous system
US5714502A (en) Piperidinylmethyloxazolidinones
MXPA96003567A (es) Derivados de la piperidinilmetiloxazolidin-2-ona
JPH08253477A (ja) 接着受容体アンタゴニスト
ES2220537T3 (es) Alcoholes de piperidina.
US6413989B1 (en) Piperidinylmethyloxazolidinone derivative
JP2005529073A (ja) ５ｈｔ−１型受容体でアフィニティーを有するヘテロサイクリルメチルピペリジンおよび−ピペラジン

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060606